Entry |
|
Name |
Pimobendan (JAN/USAN/INN); Acardi (TN) |
Formula |
C19H18N4O2
|
Exact mass |
334.143
|
Mol weight |
334.3718
|
Structure |
|
Class |
Cardiovascular agent
DG01703 Cardiotonic
DG01758 Pimobendan type cardiotonic
DG01507 Phosphodiesterase III inhibitor
DG01758 Pimobendan type cardiotonic
|
Remark |
Therapeutic category: | 2119 |
|
Efficacy |
Cardiotonic, Phosphodiesterase inhibitor |
Comment |
Calcium sensitizer
|
Target |
|
Pathway |
|
Interaction |
|
Brite |
Therapeutic category of drugs in Japan [BR:br08301]
2 Agents affecting individual organs
21 Cardiovascular agents
211 Cardiotonics
2119 Others
D01133 Pimobendan (JAN/USAN/INN)
Drug groups [BR:br08330]
Cardiovascular agent
DG01703 Cardiotonic
DG01758 Pimobendan type cardiotonic
D01133 Pimobendan
DG01507 Phosphodiesterase III inhibitor
DG01758 Pimobendan type cardiotonic
D01133 Pimobendan
Target-based classification of drugs [BR:br08310]
Enzymes
Hydrolases (EC3)
Phosphodiesterases
PDE3
D01133 Pimobendan (JAN/USAN/INN) <JP>
|
Other DBs |
|
KCF data |
ATOM 25
1 C8x C 22.8226 -19.5081
2 C8y C 21.6142 -18.8080
3 C8x C 21.6142 -17.4079
4 C8x C 22.8226 -16.7079
5 C8y C 24.0381 -18.8080
6 C8y C 24.0413 -17.4074
7 N4x N 25.3744 -16.9777
8 C8y C 26.1948 -18.1127
9 N5x N 25.3691 -19.2439
10 C2y C 20.4011 -19.5071
11 C8y C 27.5949 -18.1160
12 C8x C 28.2973 -16.9061
13 C8x C 29.6975 -16.9095
14 C8y C 30.3946 -18.1236
15 C8x C 29.6917 -19.3345
16 C8x C 28.2916 -19.3313
17 O2a O 31.7948 -18.1270
18 C1a C 32.4919 -19.3411
19 N2x N 20.4027 -20.9004
20 N1x N 19.1896 -21.5996
21 C5x C 17.9775 -20.8987
22 C1x C 17.9785 -19.4986
23 C1y C 19.1916 -18.7994
24 O5x O 16.7644 -21.5978
25 C1a C 19.1962 -17.3993
BOND 28
1 1 2 2
2 2 3 1
3 3 4 2
4 5 6 2
5 11 12 1
6 12 13 2
7 13 14 1
8 14 15 2
9 15 16 1
10 16 11 2
11 6 7 1
12 14 17 1
13 7 8 1
14 17 18 1
15 8 9 2
16 9 5 1
17 4 6 1
18 2 10 1
19 10 19 2
20 19 20 1
21 20 21 1
22 21 22 1
23 22 23 1
24 23 10 1
25 8 11 1
26 21 24 2
27 5 1 1
28 23 25 1
|